MITANT 12.5MG CAPSULE

Form: Capsules

Pack Size: 7 CAPSULES

Marketed by: HETERO HEALTHCARE LTD (ONCOLOGY DIV)

MRP: ₹301.00

HETERO HEALTHCARE LTD (ONCOLOGY DIV): Mitant 12.5MG Capsule, 7 capsules, salt sunitinib 12.5mg. NPPA has revised its MRP from Rs 536 to Rs 301 (44% lower) with effect from 09-11-2026; trade rate Rs 229.33. Group: multi-kinase inhibitor (targeted therapy). Same salt is also supplied by Natco, Pfizer, Samarth. Handling/counselling: often 4 weeks on, 2 weeks off; skin may turn yellowish - harmless. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.